The current institutional shareholding score of Genmab A/S is 3.00, ranking 192 out of 388 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 12.10%, representing a quarter-over-quarter increase of 13.72%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.72% of shares outstanding, with 0.11% increase in holdings.